Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01426919 · ClinicalTrials.gov registry record

Evaluation of Biomarkers of Traumatic Brain Injury

A clinical trial of Traumatic Brain Injury, sponsored by Banyan Biomarkers.

Completed
Registry status
2,011
Enrollment target
20
Study locations

NCT01426919 is a study of Traumatic Brain Injury that has completed, run by Banyan Biomarkers. The registered enrollment target is 2,011 participants, above the 266-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (656% higher). The trial reports 20 study locations across 13 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01426919, a study of Traumatic Brain Injury, has completed, sponsored by Banyan Biomarkers.

COMPLETED
Registry status
2,011 participants
Enrollment target
20
Study locations

Study Summary

The primary objective of this study is to evaluate the utility of the Banyan UCH-L1/GFAP Detection Assay as an aid in the evaluation of suspected traumatic brain injury (Glasgow Coma Scale score 9-15) in conjunction with other clinical information within 12 hours of injury to assist in determining the need for a CT scan of the head.

Conditions Studied

Traumatic Brain Injury

Interventions

  • OTHER Head CT scan and blood draw within 12 hours of injury

Study Locations (20)

Virginia

  • University of Virginia - Charlottesville
  • Carilion New River Valley - Christiansburg
  • Virginia Commonwealth University - Richmond

Other

  • Charité Universitätsmedizin Berlin - Campus Benjamin Franklin - Berlin
  • Charité Universitätsmedizin Berlin - Campus Virchow Klinikum - Berlin
  • University of Heidelberg - Heidelberg

Florida

  • University of Florida - Gainesville
  • Tallahassee Neurological Clinic - Tallahassee

Michigan

  • Wayne State University - Detroit Receiving Hospital - Detroit
  • Wayne State University - Sinai Grace Hospital - Detroit

Texas

  • University Medical Center Brackenridge - Austin
  • Baylor College of Medicine/Ben Taub General Hospital - Houston

California

  • University of California San Diego - San Diego

Connecticut

  • Hartford Hospital - Hartford

Massachusetts

  • University of Massachusetts Medical School - Worcester

Trial Details

FieldValue
Enrollment Target 2,011 participants
Start Date 2012-12
Est. Completion 2017-07

Sponsor

Banyan Biomarkers

8 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01426919

The ClinicalTrials.gov registry entry for NCT01426919 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,011 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 266-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (656% higher). The listed sponsor is Banyan Biomarkers, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Traumatic Brain Injury appearing as the primary indexed condition, and to 1 intervention - of which Head CT scan and blood draw within 12 hours of injury is the first listed.

NCT01426919 reports 20 study locations spanning 13 distinct geographic areas - top geographies include Virginia, Other, Florida.

Frequently Asked Questions

What is clinical trial NCT01426919 about?

NCT01426919 is a clinical study titled "Evaluation of Biomarkers of Traumatic Brain Injury". The primary objective of this study is to evaluate the utility of the Banyan UCH-L1/GFAP Detection Assay as an aid in the evaluation of suspected traumatic brain injury (Glasgow Coma Scale score 9-15) in conjunction with other clinical information within 12 hours of injury to assist in determining t...

What is the current status of trial NCT01426919?

This trial is currently completed. The enrollment target is 2,011 participants. The study started on 2012-12. Estimated completion is 2017-07.

What conditions does trial NCT01426919 study?

This clinical trial studies the following conditions: Traumatic Brain Injury.

What interventions are being tested in trial NCT01426919?

The interventions under investigation include: Head CT scan and blood draw within 12 hours of injury (OTHER).

Who is sponsoring clinical trial NCT01426919?

This trial is sponsored by Banyan Biomarkers, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01426919 being conducted?

This trial has 20 study locations across California, Connecticut, Florida, Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Traumatic Brain Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Traumatic Brain Injury

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.